NHS Palantir £330m Contract: Parliament Cancellation Debate

Today, UK Members of Parliament held a Westminster Hall debate on whether to cancel the Palantir NHS contract — a £330 million agreement giving a US surveillance company access to the medical records of millions of British patients. Palantir Technologies — the American data analytics firm founded with early CIA investment — won the NHS Federated Data Platform (FDP) contract in 2023. What transformed the political calculus: the same company also built ICE's deportation-targeting tool, which assigns a "confidence score" (a probability rating estimating the likelihood that a target lives at a given address) to individuals earmarked for removal from the United States.

The timing is acute. The contract includes a break clause that must be exercised before February 2027, and ministers have confirmed they are actively exploring it. A senior government official told the Financial Times: "We are confident we could do it if we wanted to."

The ICE Deportation Tool That Changed the Palantir NHS Data Debate

In early 2026, Palantir's work in the United States became impossible to ignore in British political circles. The company had built ELITE (Enhanced Leads Identification and Targeting for Enforcement — a bespoke platform for US Immigration and Customs Enforcement that aggregates formerly separate government datasets, including medical records, to identify people for removal). ELITE generates a visual map of deportation targets, individual dossiers on each person, and a "confidence score" indicating how certain the system is that a given address corresponds to a specific individual.

The British Medical Association (BMA) — the professional body representing the UK's 175,000 doctors — responded by calling on all members to halt non-clinical use of the NHS FDP immediately. BMA chair of council Tom Dolphin wrote publicly: "Doctors working in the NHS can no longer provide the tacit endorsement that using a product implies and must immediately take steps to explore refusing any non-direct care usage of Palantir's Federated Data Platform."

The concern is structural, not purely political: if Palantir can build a state surveillance and targeting system for one government, the same technical and legal architecture exists to replicate it for another. NHS patients include asylum seekers, undocumented residents, and migrants whose safety can depend directly on the confidentiality of their medical records.

£670 Million of UK Public Funding — The Full Scope

The NHS deal is the most visible contract, but Palantir's footprint across UK public infrastructure is far broader than most British taxpayers realise. By early 2026, the company had accumulated at least £670 million in UK public sector work:

• £330 million — the NHS Federated Data Platform (FDP), a 7-year contract awarded in 2023. A key transparency concern: the official contract award notice listed the value as £182.2 million — a £147 million discrepancy from the publicly announced figure, ending February 2027.
• Ministry of Defence — multiple analytics and surveillance contracts, debated in Parliament in February 2026.
• £15 million — a previously secret contract with AWE Nuclear Security Technologies (the agency responsible for the UK's nuclear warhead stockpile), only disclosed following investigative reporting in January 2026.
• Financial Conduct Authority (FCA) — a 12-week pilot contract to process the banking regulator's internal data: emails, call recordings, and reports of suspected financial crime. The Treasury committee (the MPs who oversee UK financial regulation) questioned whether this gives Palantir access to live fraud and insider-trading investigations.
• UK police forces — intelligence analytics contracts across multiple constabularies.

Science minister Lord Vallance has told MPs that future technology procurement will "prioritise British companies" — a widely-read signal that the government is reconsidering its dependence on a single American defence contractor for the UK's most sensitive data. For a primer on how AI data platforms handle personal information at scale, this walkthrough on AI data systems explains the key concepts.

47,000 Patients and an Unprecedented Medical Revolt

The pressure did not originate in Westminster. As of February 2026, over 47,000 individual NHS patients had sent formal letters to their local trust boards demanding withdrawal from the FDP — a level of organised public opposition to an NHS IT system that has no modern precedent in the health service's history.

Multiple NHS integrated care boards (the regional bodies coordinating hospital networks) have delayed or paused their FDP rollouts, citing internal clinical resistance. Amnesty International UK launched a formal write-to-your-MP campaign targeting the Palantir contract — one of the rare instances where a major human rights organisation has intervened in a public sector IT procurement.

Green Party MP Zack Polanski offered the bluntest parliamentary statement of the crisis, publicly telling Palantir in January 2026 to "pack its bags and get the hell out of the NHS." The Doctors Association UK, Just Treatment (a patient advocacy group), and the National Pensioners Convention are among the organisations that backed today's Westminster Hall debate.

For NHS trusts that have already deployed the FDP, withdrawal is operationally complex. The platform now handles bed management, patient journey tracking, and clinical workflow coordination. Care processes in some trusts have become dependent on it — exactly the vendor lock-in (the technical trap where switching providers becomes prohibitively costly once a system is embedded) that Committee chair Chi Onwurah MP identified as one of the three core parliamentary concerns.

The Peter Mandelson Lobbying Question

Political complications run deeper than data governance. Peter Mandelson — the Labour peer, former EU Trade Commissioner, and a central figure in current Labour networks — held a 24% stake in Global Counsel, a lobbying and advisory firm whose clients included Palantir Technologies. His consultancy connections have made it politically difficult for the government to be seen either defending or abandoning the contract without accusations of either conflict of interest or capitulation to public pressure.

The Cabinet Office has stated that Mandelson "had no involvement in the award" of the NHS contract. Senior opposition MPs are publicly unconvinced. "The truth will out," one told LBC, demanding that the full lobbying paper trail be disclosed before any decision on the break clause is announced.

Palantir's UK country head Louis Mosley has characterised criticism of the contract as coming from "ideologically motivated campaigners." That framing drew a sharp rebuttal from Chi Onwurah MP, who chairs the Science, Innovation and Technology Select Committee and led today's parliamentary scrutiny: "There may be those who have an ideological concern about data and Palantir, but there are issues around contract transparency, vendor lock-in, value for money, and data security." Onwurah added: "I think it's right the government are exploring all options, including how to break with the contract."

The NHS Palantir Contract Break Clause: 12 Months to Decide

Today's Westminster Hall debate cannot directly force government action — it is not a binding parliamentary vote. What it does is place ministers on record at precisely the moment the break clause decision has to be made. If the government does not act before the February 2027 deadline, Palantir's access to NHS data continues through the full 7-year term.

The NHS FDP creates a unified view of patient data — medical history, prescriptions, test results, appointments, and clinical notes — across NHS trusts that previously ran incompatible, siloed systems. The genuine case for it: fragmented health records cost lives in emergencies when doctors cannot see a patient's full history. The genuine case against: centralising all of that data into a platform run by a company with live contracts to help the US government locate and deport immigrants creates a conflict of interest that no technical argument resolves.

If you use the NHS in England, your patient data is likely already on the FDP unless your local trust has explicitly opted out. You can contact your GP practice or local integrated care board to ask whether your trust is participating. Foxglove's campaign page provides a direct tool to write to your MP. The break clause window closes before February 2027 — the decisions made in the next 12 months will determine whether British public health data remains in Palantir's hands for the remainder of a seven-year deal, or whether the UK begins the difficult work of rebuilding its NHS data infrastructure without a US defence contractor at the centre.

Related Content — Get Started | Guides | More News